We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

202 hedge funds and large institutions have $4.21B invested in Turning Point Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more call options, than puts

Call options by funds: $7.61M | Put options by funds: $3.16M

52% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 21

5% more funds holding

Funds holding: 193 → 202 (+9)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

13% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 80

20% less capital invested

Capital invested by funds: $5.28B → $4.21B (-$1.07B)

Holders
202
Holders Change
+9
Holders Change %
+4.66%
% of All Funds
3.55%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
32
Increased
70
Reduced
80
Closed
21
Calls
$7.61M
Puts
$3.16M
Net Calls
+$4.45M
Net Calls Change
+$2.45M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$59.5M
2
CCM
Consonance Capital Management
New York
+$53.6M
3
Victory Capital Management
Victory Capital Management
Texas
+$47M
4
CAM
Cormorant Asset Management
Massachusetts
+$42.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$30M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$45.7M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$25.5M
3
EA
Emerald Advisers
Pennsylvania
-$21M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$17.9M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$15.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$9.84M +$11.6M +97,652 +1,542%
Adage Capital Partners
52
Adage Capital Partners
Massachusetts
$9.46M -$8.92M -75,000 -43%
PCM
53
Peregrine Capital Management
Minnesota
$9.18M -$1.61M -13,570 -12%
Dimensional Fund Advisors
54
Dimensional Fund Advisors
Texas
$8.99M +$8.4M +70,618 +292%
Swiss National Bank
55
Swiss National Bank
Switzerland
$8.85M +$428K +3,600 +4%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$8.46M -$296K -2,487 -3%
DM
57
Deerfield Management
New York
$7.93M – – –
IBT
58
International Biotechnology Trust
United Kingdom
$7.71M -$3.81M -32,000 -28%
Axa
59
Axa
France
$7.71M +$180K +1,510 +2%
CM
60
Castleark Management
Illinois
$7.3M +$276K +2,325 +3%
CC
61
Casdin Capital
New York
$7.09M – – –
BCM
62
Burrage Capital Management
Massachusetts
$6.83M -$38.1K -320 -0.4%
Bank of America
63
Bank of America
North Carolina
$6.26M +$1.08M +9,122 +16%
Millennium Management
64
Millennium Management
New York
$6.17M +$6.63M +55,740 +584%
FAM
65
Fred Alger Management
New York
$6.03M -$104K -875 -1%
FLAM
66
First Light Asset Management
Minnesota
$5.57M +$380K +3,198 +6%
Allianz Asset Management
67
Allianz Asset Management
Germany
$5.38M -$1.19M -10,001 -15%
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
$5.33M -$20.2K -170 -0.3%
Deutsche Bank
69
Deutsche Bank
Germany
$5.29M -$365K -3,070 -5%
OCM
70
Osterweis Capital Management
California
$5.28M +$517K +4,350 +8%
PI
71
Putnam Investments
Massachusetts
$5.28M +$125K +1,054 +2%
State of Wisconsin Investment Board
72
State of Wisconsin Investment Board
Wisconsin
$5.07M -$71.3K -600 -1%
WCM Investment Management
73
WCM Investment Management
California
$4.94M -$129K -1,085 -2%
TD Asset Management
74
TD Asset Management
Ontario, Canada
$4.93M +$490K +4,119 +9%
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$4.85M -$357K -3,001 -6%
1 2
3
4 5

TPTX Hedge Fund Activity: Q1 2021 in Review

202 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q1 2021, worth a combined $4.21B — down 20% from $5.28B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new TPTX positions and 21 closed out — a net gain of 11 holders — while 70 added to existing stakes and 80 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $59.5M. The largest seller was OrbiMed, cutting an estimated $45.7M.

  • 202 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q1 2021, up from 193 in Q4 2020.
  • Funds reported $4.21B of Turning Point Therapeutics, Inc. Common Stock stock for Q1 2021, down 20% quarter-over-quarter.
  • 32 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q1 2021 and 21 closed out, a net change of +11 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q1 2021 was Farallon Capital Management, an estimated $59.5M added.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q1 2021 was OrbiMed, an estimated $45.7M sold.

Based on aggregated 13F filings for Q1 2021.